EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist

Changpeng Zhu, Weihua Dong, Huaqiang Liao, Yong Lin iD, Weifen Xie iD

Journal of Translational Internal Medicine · 25.06.2026 · 14 (3) · 481-484

DOI: 10.1515/jtim-2026-0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 04.04.2026. Verfasst von Changpeng Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Department of Interventional Radiology, Changzheng Hospital, Naval Medical University, Shanghai, China.

ORCID-Profile: Yong Lin, Weifen Xie

Zitieren

APA

Zhu, C., Dong, W., Liao, H., Lin, Y., & Xie, W. (2026). Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist. Journal of Translational Internal Medicine, 14(3), 481-484. https://doi.org/10.1515/jtim-2026-0012

Vancouver

Zhu C, Dong W, Liao H, Lin Y, Xie W. Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist. Journal of Translational Internal Medicine. 2026;14(3):481-484. doi:10.1515/jtim-2026-0012

BibTeX
@article{Zhu2026,
  author = {Zhu, Changpeng and Dong, Weihua and Liao, Huaqiang and Lin, Yong and Xie, Weifen},
  title = {Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist},
  journal = {Journal of Translational Internal Medicine},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {481--484},
  doi = {10.1515/jtim-2026-0012}
}
Kostenlos starten →